Skip to content

Conducting A Study On Video Observed Therapy In The Management Of Tuberculosis

Effectiveness of Video Observed Therapy in the Management of Tuberculosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05994144
Acronym
VOT
Enrollment
240
Registered
2023-08-16
Start date
2023-12-01
Completion date
2024-06-30
Last updated
2023-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

Tuberculosis, Digital health, video observed therapy, treatment adherence

Brief summary

The aim of this study is to measure the effectiveness usage of VOT in the treatment of TB in terms of treatment adherence. The study will be a randomized controlled trial and will involve 240 TB patients. The study is aimed to commence by December 2023. The study period will be for 4 months.

Detailed description

There is an urgent need to produce an integrated e-health system in tackling the issue of remote monitoring for patient adherence. For example, in TB infection which requires close monitoring for better treatment outcomes. The usage of digital health products replacing the traditional DOTS will be a cost-effective method and will also bode convenient for patients and staff. Video Observed Therapy (VOT) usage as the alternative digital health method replacing traditional DOTS will be more effective in tackling adherence issues. This method has already been tried in many countries like the United States of America (USA), the United Kingdom (UK), Italy, and Moldova, and has proven to be more effective than traditional DOTS. For instance, a study by Story et al. reveals that a total of 70% of patients on VOT successfully completed ≥80% of a 2-month observation compared with only 31% of those on traditional DOTS (95% CI 3.10 to 9.68). A proposed intervention of adapting VOT in TB treatment is a practical move, as it can improve treatment compliance and also has the added benefit of being cost-effective. 1.4 Research Question What is the effectiveness of Video Observed Therapy (VOT) in the management of tuberculosis (TB) compared to the traditional Directly Observed Treatment Short Course Strategy (DOTS)? 1.5 Study Objectives 1.5.1 General Objective The general objective of this study is to compare the effectiveness of VOT with traditional DOTS in the management of TB. 1.5.2 Specific Objectives I. To develop VOT intervention in the management of TB. II. To compare the effectiveness of VOT as compared to traditional DOTS. III. To measure patient satisfaction using VOT.

Interventions

OTHERVIDEO OBSERVED THERAPY

Video-observed therapy is the usage of teleconferencing to observe anti-TB medication ingestion.

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

For all participants who are randomised into VOT arm or traditional DOTS arm. Control group : Patients allocated into the traditional DOTS arm will follow the usual protocol as all other patients assigned to DOTS under Ministry of Health Malaysia Intervention group : Patient will be observed on their daily TB medication consumption via teleconference by using WhatsApp video call.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

i. All PTB smear-positive patients. ii. Patients aged 18 years and above. iii. Possess a digital phone or other equivalent gadget equipped with a WhatsApp application. iv. Able to accurately identify each TB medication.

Exclusion criteria

i. Recurrent PTB infection. ii. Patients who are extremely ill, have no proper social support, no caretakers, and are hospitalized. iii. Patients in prison during the time of diagnosis or treatment.

Design outcomes

Primary

MeasureTime frameDescription
Treatment adherence in percentage from both arms60 daysNumber of days medicine consumed/over 60 days intensive period

Secondary

MeasureTime frameDescription
Side effects incidents report60 daysNumber of reported side effects detected from both arms.
Patients suffering with side effects60 daysNumber of patients having side effects detected from both arms.
Seroconversion rate60 daysNumber of successful sero-conversion patients from sputum smear positive to sputum smear negative by the end of the intensive phase.
Time save120 daysOverall time spent by patients from both arms.
Cost saving60 daysOverall money spent by patients from both arms.
Degree of patient's satisfactionQuestionnaire using Likert scale. Score 1:least satisfied,Score 5: most satisfiedThe degree of satisfaction of the participants from both arms.

Countries

Malaysia

Contacts

Primary ContactKARTIK KALIYANA SUNDARAM, MPH
kartik25@hotmail.com0060124975343

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026